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Children with complex congenital heart diseases often require repeated cardiac catheterization; however,
children are more radiosensitive than adults. Therefore, radiation-induced carcinogenesis is an important
consideration for children who undergo those procedures. We measured entrance skin doses (ESDs) using
radio-photoluminescence dosimeter (RPLD) chips during cardiac catheterization for 15 pediatric patients
(median age, 1.92 years; males, n = 9; females, n = 6) with cardiac diseases. Four RPLD chips were placed on
the patient’s posterior and right side of the chest. Correlations between maximum ESD and dose–area products
(DAP), total number of frames, total fluoroscopic time, number of cine runs, cumulative dose at the interven-
tional reference point (IRP), body weight, chest thickness, and height were analyzed. The maximum ESD was
80 ± 59 (mean ± standard deviation) mGy. Maximum ESD closely correlated with both DAP (r = 0.78) and
cumulative dose at the IRP (r = 0.82). Maximum ESD for coiling and ballooning tended to be higher than that
for ablation, balloon atrial septostomy, and diagnostic procedures. In conclusion, we directly measured ESD
using RPLD chips and found that maximum ESD could be estimated in real-time using angiographic para-
meters, such as DAP and cumulative dose at the IRP. Children requiring repeated catheterizations would be
exposed to high radiation levels throughout their lives, although treatment influences radiation dose.
Therefore, the radiation dose associated with individual cardiac catheterizations should be analyzed, and the
effects of radiation throughout the lives of such patients should be followed.
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INTRODUCTION
The incidence of congenital cardiac diseases is ~1% [1].
Cardiac catheterization is an essential procedure for precise
diagnosis and/or treatment for congenital cardiac diseases.
However, complex cardiac catheterization procedures result
in higher radiation doses due to a longer fluoroscopy time,
and congenital cardiac diseases often require repeated cath-
eterization procedures for staged operations and for their
follow-ups, resulting in a large cumulative lifetime radiation
dose per individual. Meanwhile, due to advancements in
treatment technique in recent years, the number of long-term
survivors is increasing. Therefore, reducing radiation doses
during pediatric cardiac catheterizations is an important issue
with respect to improving the quality of life for survivors.
The risks of radiation-induced late effect, such as leukemia
and solid cancer, are greater in children than in adults [2, 3].
Among different sites and types of cancer, the risk of devel-
oping non-melanoma skin cancer and thyroid cancer is much
higher in children relative to adults among those exposed to
atomic bomb radiation [3]. Therefore, unnecessary exposure
of the thyroid or skin to radiation should be avoided as much
as possible in young patients undergoing cardiac catheteri-
zations. Furthermore, it is necessary to reduce the area
exposed, as the heart to body ratio is much greater in a child
than in an adult. However, only a few studies have investi-
gated radiation exposure and its distribution during pediatric
catheterizations for congenital heart disease [4–6]. Thus, to
increase the safety of interventional procedures for children,
the lifetime total entrance skin dose (ESD) and its geometric
distribution should be measured in individuals.
A radio-photoluminescence dosimeter (RPLD) has been
used for direct measurement of patients’ ESD, because
RPLD is sensitive to X-rays with sufficient accuracy through
a wide range (10 μGy to 500 Gy) of detection and because it
can be placed at many points on the skin surface due to its
small size and radiolucency under fluoroscopy and cine run
(Fig. 1B and C) [7–12]. Therefore, this study evaluated the
ESD and its distribution using RPLD chips for patients with
congenital heart diseases who were treated via catheteriza-
tion. In addition, we analyzed the correlation between the
maximum ESD and several angiographic parameters and
body parameters so as to easily predict maximum ESD in
future cases without the need for ESD measurements using
RPLD.
MATERIALS ANDMETHODS
Patients
ESD dosimetry was performed in 15 cases from March to
December 2008 (Table 1). The patients were selected at
random. The patients were comprised of nine males and six
females with a median age of 1 year and 11 months old
(range, 1 month to 11 years and 11 months) and a median
weight of 9 kg (range, 3 kg to 48 kg).
This study was conducted in accordance with the Declaration
of Helsinki. All protocols were approved by Yokohama City
University Hospital (Yokohama, Japan). Written informed
consent was obtained from patients’ parents before commen-
cing procedures.
Angiogram technique
A biplane X-ray imaging system equipped with two image
intensifiers and a digital cine mode (INFX-8000 V/JB,
Toshiba, Japan) was used. The X-ray fluoroscopic unit was
used with the following conditions: source-to-image-intensifier
distances of 90 cm for frontal view and 110 cm for lateral
view, an image intensifier field size of 12.7 cm, a tube poten-
tial of 75 kVp, and an acquisition rate of 7.5–30 frames per
second for pulsed fluoroscopy. A 0.3-mm thick copper filter
was added for fluoroscopy. For cine angiography, a 1.8-mm
thick aluminum filter was inserted automatically.
Dose–area product (DAP), total number of frames, total
fluoroscopic time, number of cine runs, cumulative dose at
the interventional reference point (IRP), body weight, chest
thickness, and height were recorded. Among these values,
DAP, total number of frames, and total fluoroscopic time
were total values for both planes (total value = frontal plane
Fig. 1. Radio-photoluminescence dosimeter (RPLD) chips were
placed on the posterior chest and right lateral chest. (A) Schema
of the site of the RPLD chips. The number shows the position
number for RPLD placement. (B) Typical angiogram (PA view).
(C) Typical angiogram (RL view). Arrows indicate RPLD chips.
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value + lateral plane value). We also used the double product
of body parameter and total fluoroscopic time, which are the
weight–total fluoroscopic time product, the chest thickness–
total fluoroscopic time product, and the height–total fluoro-
scopic time product.
Dosimetry technique
Patient ESD was measured using small RPLD chips
(Chiyoda Technol Co., Tokyo, Japan). The RPLD chip is
8-mm square and 1-mm thick with sufficient radiolucency
for fluoroscopy. Each chip was wrapped in a thin plastic film
in order to avoid staining from sweat or blood during the
interventional procedures. Three wrapped RPLD chips were
placed on the posterior chest (Positions Nos 1, 2 and 3 in
Fig. 1A), and one wrapped RPLD chip was placed on the
right lateral chest (Position No. 4 in Fig. 1A).
The dose response of RPLD is susceptible to the X-ray
energy at the range normally used for angiography (30–40
keV). Therefore, an average calibration factor to adjust the
RPLD readout value to the ESD was calculated and then
used as described previously [9, 12].
Statistical analysis
Correlations between maximum ESD and DAP, total number
of frames, total fluoroscopic time, number of cine runs, cu-
mulative dose at the IRP, weight, chest thickness, and height
were analyzed using linear regression. Student’s t-test was
used to compare the two procedure groups. Statistical signifi-
cance was defined as a P-value of less than 0.05.
RESULTS
The patients’ age, weight, height, chest thickness, sex,
disease, interventional radiology procedure, and number of
cardiac catheterizations are summarized in Table 1. Three
patients underwent cardiac catheterization for diagnostic pur-
poses. The remaining 12 patients underwent interventional
radiology (therapeutic) procedures. The therapeutic proce-
dures were divided into four groups: coil embolization,
balloon dilatation, ablation, and balloon atrial septostomy
(BAS). Of the 15 patients, 13 underwent multiple cardiac
catheterizations during the observation period.
Table 1. Characteristics of the pediatric patients in our study
Case Age
Weight
(kg)
Height
(cm)
Chest
thickness
(mm)
Sex Disease Procedure
Number of cardiac
catheterizations
(follow-up period)
1 8 y 6 m 31 128 160 M PDA PDA coiling 1 (5 y 7 m)
2 0 y 1 m 3 50 85 M PA/IVS
Ebstein
BAS 5 (5 y 1 m)
3 0 y 11 m 8 71 90 M TGA PA ballooning 5 (5 y 9 m)
4 2 y 2 m 9 79 102 F DORV Diagnosis 6 (7 y 1 m)
5 1y 11 m 11 86 106 M TOF PA ballooning 5 (6 y 11 m)
6 0 y 3 m 4 53 no data M AoC, VSD, PS Diagnosis 3 (3 y 7 m)
7 1 y 9 m 9 78 106 M DORV PA ballooning 6 (6 y 8 m)
8 2 y 6 m 10 81 140 F DORV PA ballooning 12 (9 y 5 m)
9 2 y 3 m 10 85 112 F PA/IVS PA ballooning 10 (7 y 1 m)
10 2 y 10 m 13 95 115 M cTGA Aortopulmonary
collateral vessels
coiling
8 (7 y 6 m)
11 0 y 1 m 3 50 83 M HLHS BAS 9 (4 y 8 m)
12 0 y 7 m 8 69 87 F PS, AS PA ballooning 5 (5 y 0 m)
13 0 y 10 m 10 75 98 F DORV Coiling 3 (5 y 5 m)
14 11 y 11 m 48 150 129 F WPW Ablation 1 (5 y 10 m)
15 0 y 3 m 4 50 no data M HLHS Diagnosis 9 (4 y 8 m)
Case 11 and Case 15 are the same patient. AoC = aortic coarctation, AS = aortic stenosis, BAS = balloon atrial septostomy,
cTGA = corrected transposition of great arteries, DORV = double-outlet right ventricle, HLHS = hypoplastic left heart syndrome, PA
ballooning = pulmonary artery ballooning, PA/IVS = pulmonary atresia with intact ventricular septum, PDA = patent ductus
arteriosus, PDA coiling = patent ductus arteriosus coiling, PS = pulmonary stenosis, TOF = Tetralogy of Fallot, VSD = ventricular
septal defect, WPW =Wolff–Parkinson–White syndrome.
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Table 2 summarizes maximum ESD (the largest ESD
value recorded from the four RPLD chips put on the patient’s
skin), DAP, total number of frames, total fluoroscopic time,
number of cine runs, and cumulative dose at the IRP of
patients.
We investigated the relationship between maximum ESD
and angiographic parameters (Fig. 2). DAP (r = 0.78,
P < 0.001), total number of frames (r = 0.83, P < 0.001),
number of cine runs (r = 0.87, P < 0.001), and cumulative
dose at the IRP (r = 0.82, P < 0.001) showed good correla-
tions with maximum ESD, whereas total fluoroscopic
time poorly correlated with maximum ESD (r = 0.56,
P = 0.029) (Fig. 2A–E, Table 3). Body weight (r = −0.10,
P = 0.721), chest thickness (r = −0.06, P = 0.846), and height
(r = 0.07, P = 0.801) did not correlate with maximum ESD
(Fig. 2F–H, Table 3).
After eliminating two outlier cases with ages older than 3
years (Cases 1 and 14 in Tables 1 and 2), the correlation co-
efficient (r) between maximum ESD and body weight and
height markedly increased to 0.63 (P = 0.020) (Fig. 2F,
Table 3) and 0.59 (P = 0.032) (Fig. 2H, Table 3), respective-
ly. In contrast, the correlation coefficients between maximum
ESD and DAP (r = 0.81, P < 0.001), total number of frames
(r = 0.81, P < 0.001), total fluoroscopic time (r = 0.60,
P = 0.029), number of cine runs (r = 0.86, P < 0.001), cumu-
lative dose at the IRP (r = 0.97, P < 0.001) and chest
thickness (r = 0.17, P = 0.613) did not change so much (Fig.
2A–E and G, Table 3).
When the DAP meter is not equipped with a fluoroscopy
unit, or when the cumulative dose at the IRP cannot be
displayed, the only total fluoroscopic time is available in
real-time during catheterization. Therefore, we investigated
the relationship between maximum ESD and the double
product of body parameters (i.e. body weight, chest thick-
ness, and height) and total fluoroscopic time after elimin-
ation of the two outlier cases. The correlation coefficients
for weight–total fluoroscopic time product, the chest thick-
ness–total fluoroscopic time product, and the height–total
fluoroscopic time product were 0.88 (P < 0.001), 0.62
(P = 0.041), and 0.83 (P < 0.001), respectively (Fig. 3,
Table 4), which are much higher than the values without
the double product.
Figure 4 shows the maximum ESD for different proce-
dures. Maximum ESD (mean ± standard deviation) in the
group undergoing coiling (120 ± 80 mGy, n = 3) or balloon-
ing (110 ± 50 mGy, n = 6) tended to be higher than that of
patients undergoing ablation (23 mGy, n = 1), BAS (39 ± 38
mGy, n = 2) or diagnostic angiography (37 ± 12 mGy, n = 3)
(P = 0.010).
As for the dose distribution, the number of patients who
showed the maximum ESD in RPLD Position Nos1, 2, 3 and
4 were four, seven, one and three, respectively (Fig. 5).
Table 2. Maximum ESDs and angiographic parameters in our study
Case
Maximum ESD
(mGy)
DAP
(cGy × cm2)
Total number
of frames
Total fluoroscopic
time (s)
Number of
cine runs
Cumulative dose at
the IRP (Gy)
1 71 3 208.9 1 676 1 467 19 0.2
2 66 1 018.6 1 076 7 150 13 0.1
3 150 2 875.7 5 873 3 875 35 0.3
4 50 586.1 1 963 1 077 16 0.1
5 140 3 119.5 4 342 4 132 44 0.3
6 34 598.0 1 242 3 167 16 0.1
7 49 1 571.8 1 948 1 534 24 0.1
8 100 3 124.8 2 702 4 356 35 0.2
9 44 2 704.9 1 873 1 952 16 0.1
10 210 8 627.3 2 998 5 390 35 0.4
11 12 145.7 231 1 334 8 0.0
12 160 2 766.2 4 314 4 166 50 0.3
13 66 2 832.7 1 627 3 967 25 0.2
14 23 2 364.1 50 3 530 14 0.3
15 26 1 436.9 801 806 12 0.1
Average 80 2 465.4 2 181.1 3 193.5 24.1 0.2
SD 59 2 003.5 1 623.5 1 807.6 12.8 0.1
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DISCUSSION
Reducing unnecessary X-ray exposure during cardiac cath-
eterization is of great importance for pediatric patients,
because these patients have high tissue susceptibility to ion-
izing radiation [13]. For medical exposure, the maximum
ESD should not exceed the threshold dose that causes the
deterministic effect. However, the largest value for the
maximum ESD in this study was 210 mGy (Case 10 in
Table 2), which is far below the 2-Gy threshold dose for tem-
porary erythema [14]. In fact, skin injury did not occur after
the procedure.
As for the stochastic effect, a previous study of Hiroshima
and Nagasaki atomic bomb survivors indicated that children
Fig. 2. Correlations between maximum entrance skin dose (ESD) and angiographic and body parameters. Closed diamonds indicate
patients younger than 3 years; open diamonds indicate patients older than 3 years. Solid lines on the graphs indicate linear regressions for all
patients; dashed lines on the graphs indicate linear regressions for patients younger than 3 years. (A) Correlation between maximum ESD
and dose–area product (DAP). (B) Correlation between maximum ESD and total number of frames. (C) Correlation between maximum ESD
and total fluoroscopic time. (D) Correlation between maximum ESD and number of cine runs. (E) Correlation between maximum ESD and
cumulative dose at the interventional reference point (IRP). (F) Correlation between maximum ESD and weight. (G) Correlation between
maximum ESD and chest thickness. (H) Correlation between maximum ESD and height.
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younger than 20 years are more susceptible than adults to in-
duction of cancers [15]. Moreover, Mathews et al. showed
that undergoing CT scans during childhood and adolescence
is followed by an increase in cancer incidence for all cancers
combined and for many individual types of cancer [16].
Sasaki et al. showed that mice exposed to radiation while in
infancy had a significantly decreased lifespan and an in-
crease in the incidence of cancer when compared with mice
exposed as adults [17]. These observations suggest that
radiation-induced cancer risks in children who undergo
cardiac catheterization are likely to be higher than those for
adults. In particular, the risk of radiation-induced skin and
thyroid cancer is higher in younger (10 years of age) than in
older patients (50 years of age) based on an analysis of site-
specific sex-averaged excess relative risk and excess absolute
rate attained at age 70 after atomic bomb radiation exposure
[3]. According to their report, interventional procedures for
congenital heart disease could be associated with higher
risks for solid cancer, because the thyroid is located much
closer to the heart in children than in adults and because skin
irradiation is inevitable when patients require X-ray fluoros-
copy. Furthermore, when a small child is treated with the
same size of the field exposed, the totally irradiated body
fraction is larger when compared with that of an adult, which
means an increase in the effective dose for children during
cardiac catheterization.
DAP is defined as the absorbed dose multiplied by the
area irradiated; therefore, DAP reflects not only the dose
within the radiation field but also the area of tissue irradiated.
Bacher et al. reported a good correlation (r = 0.90) between
peak ESD and DAP in pediatric catheterization [14].We also
found a good correlation (r = 0.78) between maximum ESD
and DAP in this study (Fig. 2A, Table 3). Among the para-
meters analyzed, DAP could be a useful indicator for predict-
ing the maximum ESD, since it has the advantages of being
easily measured in real time via the permanent installation of
a DAP meter on the X-ray fluoroscopic unit. For the same
reason, it would be useful in clinical settings to have an indi-
cator of the cumulative dose at the IRP (r = 0.82) (Fig. 2E,
Table 3), which is located on the central ray of the X-ray
beam, 15 cm from the isocenter toward the focal spot.
Chida et al. reported a good correlation between DAP and
weight in cardiac catheterization for both the diagnostic (r =
0.819) and the therapeutic (r = 0.895) procedures in children;
this is because the X-ray output to the larger patients is
usually greater [2]. According to this theory, the maximum
ESD is a strong determinant of DAP and should correlate
with body parameters, such as weight, chest thickness, and
height. However, we found no correlation between maximum
ESD and those parameters (weight, r = −0.10; chest thickness,
r = −0.06; height, r = 0.07) (Fig. 2F–H, Table 3). One explan-
ation for our results is that outlier cases with large body size
were included in our study. Indeed, Chida et al. reported a
poor correlation between weight and radiation dose for adult
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patients [2, 18, 19]. When the two outliers (Cases 1 and 4 on
Table 1) were eliminated, the correlation coefficient between
maximum ESD and weight and height increased to 0.63
(Fig. 2F, Table 3) and 0.59 (Fig. 2H, Table 3), respectively.
Hence body weight and height could correlate with maximum
ESD for children younger than 3 years.
The correlation coefficients between maximum ESD and
double products of body parameter–total fluoroscopic time
products were much higher than those for body parameters
alone (Fig. 3, Table 4). Total fluoroscopic time and body
parameters are always available in real time; therefore, when
DAP or cumulative dose at the IRP cannot be monitored
during the procedure, body parameter–fluoroscopic time pro-
ducts could be a surrogate indicator for the maximum ESD
during cardiac catheterization for pediatric patients younger
than 3 years.
Maximum ESDs for coiling and ballooning procedures
tended to be higher (P = 0.010) than that for ablation, BAS
and diagnostic procedures (Fig. 4). This trend is probably
related to the fact that coiling and ballooning techniques
require longer procedural times, as previously reported [2].
In our study, this trend in maximum ESD was more similar
to the trend in total number of frames (Suppl. Fig. 1B) and
number of cine runs (Suppl. Fig. 1D) than to total
fluoroscopic time (Suppl. Fig. 1C), which is probably
because the maximum ESD was more affected in cine than in
fluoroscopy. Thus, avoidance of unnecessary cine runs, espe-
cially during coiling and ballooning procedures, is war-
ranted.
The maximum ESD was distributed at around the upper
posterior chest (Position Nos 1 and 2 in Fig. 1A) (Fig. 5).
Three patients (20%) showed maximum ESD in the right
lateral chest (Position No. 4 in Fig. 1A) (Fig. 5). A previous
report demonstrated a wide variation in the location of
maximum ESD after cardiac interventional radiology pro-
cedures in adults [10]. Our results also showed that the
maximum ESD spread in the posterior and lateral chest
during pediatric cardiac catheterization (Fig. 5); therefore,
the radiation dose as well as its location must be evaluated
for each procedure.
There are some limitations in this study. One limitation is
the small number (n = 4) of RPLD chips placed on the
patient to represent the whole area exposed to X-rays.
Another limitation is that the statistical analysis of the
small number of patients (n = 15) contains high uncertainty.
Therefore, we are now developing a jacket equipped with an
RPLD chip that can obtain more precise dose distributions.
This system will provide us with a better understanding of
Table 4. Linear regression lines in Fig. 3
Outcome
variable (y)
Predictor variable (x) Regression line
Correlation
coefficient (r)
Coefficient of
determination (r2)
P-value Remarks
Maximum
ESD (mGy)
Weight–total fluoroscopic
time product (kg × s)
y = 0.0028x + 10.9535 0.88 0.77 < 0.001 Solid line on
Fig. 3A
Chest thickness–total
fluoroscopic time
product (mm × s)
y = 0.0002x + 24.6247 0.62 0.39 0.041 Solid line on
Fig. 3B
Height–total fluoroscopic
time product (cm × s)
y = 0.0004x + 0.3735 0.83 0.68 < 0.001 Solid line on
Fig. 3C
Fig. 3. Correlations between maximum ESD and double products of body parameter and total fluoroscopic time for patients younger than
3 years. (A) Correlation between maximum ESD and weight–total fluoroscopic time product. (B) Correlation between the maximum ESD
and chest thickness–total fluoroscopic time product. (C) Correlation between the maximum ESD and height–total fluoroscopic time product.
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the radiation dose necessary to reduce the risk of late effects
from pediatric interventional radiology.
In this study, we measured the maximum ESD using
RPLD chips and analyzed its correlation with factors related
to cardiac catheterization in children. DAP and cumulative
dose at the IRP were found to be useful parameters for pre-
dicting the maximum ESD in real time during the procedure.
When neither DAP nor the IRP can be monitored, the body
parameter–total fluoroscopic time product, especially weight–
total fluoroscopic time product and height–total fluoroscopic
time, could be a useful surrogate indicator of the maximum
ESD for children younger than 3 years. The maximum ESD
was strongly influenced by the treatment procedure; therefore,
children who need repeated catheterization for complex con-
genital heart disease should undergo measurement of their
total radiation doses and its location through their lifespans.
SUPPLEMENTARY DATA
Supplementary data is available at the Journal of Radiation
Research online.
ACKNOWLEDGEMENTS
The Clinical Trial Registration Number of the Yokohama
City University Hospital Institutional Review Board is
Approval No. 118.
FUNDING
This research is partly supported by institutional sources and
in part by Grants-in-Aid (Nos 21611012 and 24300179)
from the Ministry of Education, Science, Sports and Culture
of Japan. Funding to pay the Open Access publication
charges for this article was provided by Grants-in-Aid (No.
26293135) from the Ministry of Education, Science, Sports
and Culture of Japan.
REFERENCES
1. Mitchell SC, Korones SB, Berendes HW. Congenital heart
disease in 56,109 births. Incidence and natural history.
Circulation 1971;43:323–32.
2. Chida K, Ohno T, Kakizaki S et al. Radiation dose to the pedi-
atric cardiac catheterization and intervention patient. Am J
Roentgenol 2010;195:1175–9.
3. Preston DL, Ron E, Tokuoka S et al. Solid cancer incidence in
atomic bomb survivors: 1958–1998. Radiat Res 2007;168:1–64.
4. Schueler BA, Julsrud PR, Gray JE et al. Radiation exposure
and efficacy of exposure-reduction techniques during cardiac
catheterization in children. Am J Roentgenol 1994;162:173–7.
5. Waldman JD, Rummerfield PS, Gilpin EA et al. Radiation ex-
posure to the child during cardiac catheterization. Circulation
1981;64:158–63.
6. Boothroyd A, McDonald E, Moores BM et al. Radiation ex-
posure to children during cardiac catheterization. Br J Radiol
1997;70:180–5.
7. Hayakawa M, Moritake T, Kataoka F et al. Direct measurement
of patient’s entrance skin dose during neurointerventional pro-
cedure to avoid further radiation-induced skin injuries. Clin
Neurol Neurosurg 2010;112:530–6.
8. Moritake T, Hayakawa M, Matsumaru Y et al. Precise mapping
system of entrance skin dose during endovascular embolization
for cerebral aneurysm. Radiat Meas 2011;46:2103–6.
9. Moritake T, Matsumaru Y, Takigawa T et al. Dose measure-
ment on both patients and operators during neurointerventional
procedures using photoluminescence glass dosimeters. Am J
Neuroradiol 2008;29:1910–7.
Fig. 4. Maximum ESD in different procedures. Data indicate
mean + standard deviation (SD).
Fig. 5. Number of patients who showed the maximum ESD at
each position. The number on the horizontal axis shows the position
number for RPLD placement as indicated in Fig. 1A.
Prediction of skin dose via angiographic parameter 1129
10. Chida K, Kato M, Kagaya Y et al. Radiation dose and radiation
protection for patients and physicians during interventional
procedure. J Radiat Res 2010;51:97–105.
11. Kato M, Chida K, Moritake T et al. (24 November 2013)
Fundamental study on the characteristics of a radiophotolumi-
nescence glass dosemeter with no energy compensation filter
for measuring patient entrance doses in cardiac interventional
procedures. Radiat Prot Dosimetry.
12. Nishizawa K, Moritake T, Matsumaru Y et al. Dose measure-
ment for patients and physicians using a glass dosemeter
during endovascular treatment for brain disease. Radiat Prot
Dosimetry 2003;107:247–52.
13. Richardson RB. Past and revised risk estimates for cancer
induced by irradiation and their influence on dose limits. Br J
Radiol 1990;63:235–45.
14. Bacher K, Bogaert E, Lapere R et al. Patient-specific dose and
radiation risk estimation in pediatric cardiac catheterization.
Circulation 2005;111:83–9.
15. Land CE, Tokunaga M, Koyama K et al. Incidence of female
breast cancer among atomic bomb survivors, Hiroshima and
Nagasaki, 1950–1990. Radiat Res 2003;160:707–17.
16. Mathews JD, Forsythe AV, Brady Z et al. Cancer risk in
680,000 people exposed to computed tomography scans in
childhood or adolescence: data linkage study of 11 million
Australians. BMJ 2013;346:f2360.
17. Sasaki S, Fukuda N. Temporal variation of excess mortality
rate from solid tumors in mice irradiated at various ages with
gamma rays. J Radiat Res 2005;46:1–19.
18. Chida K, Saito H, Otani H et al. Relationship between fluoro-
scopic time, dose–area product, body weight, and maximum
radiation skin dose in cardiac interventional procedures. Am J
Roentgenol 2006;186:774–8.
19. Chida K, Saito H, Kagaya Y et al. Indicators of the maximum
radiation dose to the skin during percutaneous coronary inter-
vention in different target vessels. Catheter Cardiovasc Interv
2006;68:236–41.
L. Sun et al.1130
